Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Trial Profile

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Aug 2018

At a glance

  • Drugs Enzalutamide (Primary) ; Enzalutamide
  • Indications Prostate cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Aug 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 3 Aug 2018 to 9 Aug 2018.
    • 28 Jul 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 31 Jul 2018 to 3 Aug 2018.
    • 25 Jul 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 3 Jul 2018 to 31 Jul 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top